Latest Breaking News On - Ptab invalidates united therapeutics patent relating to the hypertension drug tyvaso xae - Page 1 : comparemela.com

In Liquidia Techs., Inc. v. United Therapeutics Corp.,[1] the Patent Trial and Appeal Board ("the PTAB") held all challenged claims of U.S. Patent No. 10,716,793 ("the '793 patent") unpatentable under 35 U.S.C. § 103.

Liquidia techs incFox factory incLiquidia techsPatent trialAppeal boardUnited therapeuticLoreal united statesPtab invalidates united therapeutics patent relating to the hypertension drug tyvaso xaeIntellectual property